莫西沙星与环丙沙星_甲硝唑预防重_急性胰腺炎腹腔感染的随机对照研究.pdfVIP

# 830 # 2007 12 15 12 J Clin Surg, D c m b r 2007, Vol. 15, No. 12 ## + 刘涛 周静 禹峰 吴河水 熊炯火斤 周峰 王春友 [ ] , 400 mg, 400 mg+ 1. 25 g, 7~ 14 d, APA CH Ò , 28 , 2625 , 24 14. 3% , 17. 9% ; 15. 3% , 20% , + [ ] ; ; ; + [ ] R657. 5 1 [ ] A [ ] 1005-6483( 2007) 12-0830-03 Randomized controlled trial of moxifloxacin vs ciprofloxacin plus arilinin the preven- tion of abdominal infection in severe acute pancreatitis L I U Tao, ZH O U Jing , Y U Feng , et al . ( Center of P a ncreatic S urgery , Union H osp ital , Tong i M ed i ca l Colleg e, H uaz hong Univ ersi ty of S cience and Technology , W uha n 430022, Chi na) [Abstract] Objective T o valuat th fficacy and saf t y of moxifloxacin in th pr v ntion of inf ction in s v r acut pancr atitis. Methods Pati nts w ith s v r acut pancr atit is w r random- ly arrang d to r c iv ith r mox iflox acin 400 mg for 7~ 14 days or ciproflox acin 400 mg plus arilin 1. 25 g for 7~ 14 days. Th ir vital sign, APA CH Ò scor , blood routin , liv r function and r nal function, as w ll as obj ctiv signs such as naus a, vomiting, abdominal pain and dist nsion w r r cord d. T h ir d ath rat and incid nc of inf ction w r analyz d. Results Th r w r 28 pati nts nroll d in ach group: 26 in moxiflox acin group and 25 in ciprofloxacin plus arilin group could r c iv curativ ff ct valuation, and 24 pati nts in ach group could r c iv saf ty valuation. Th incid nc of abdominal inf ction in mox iflox acin group and ciprofloxacin plus arilin group w as 14. 3% and 17. 9% r sp ctiv ly . Th incid nc of adv rs ff ct in moxifloxacin group and ciprofloxacin plus arilin group was 15. 3